Neurosurgeons at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center are among the first in the world to utilize real-time magnetic resonance imaging (MRI) guidance for delivery of gene therapy as a potential treatment for brain tumors. This new approach offers a precise way to deliver a therapeutic virus designed to make the tumor susceptible to cancer-killing drugs.
This could be a good news to glioblastoma patients. This MRI-guided approach will help us deliver this drug into the tumor directly to see if the drug is working,” says Santosh Kesari, principal investigator and director of neuro-oncology at Moores Cancer Center. “This approach may lead to new treatment options for patients battling several other types of brain cancers.”